Elbonix 50mg Tab 28s

Elbonix 50 mg Tablets contains eltrombopag, a thrombopoietin receptor agonist used to treat low platelet count (thrombocytopenia) in patients with chronic blood disorders. It helps stimulate platelet production and reduces the risk of bleeding.

What is Elbonix 50 mg Tablet?

Elbonix (eltrombopag) is an oral medication that works by activating receptors in the bone marrow to increase platelet production. It is commonly prescribed when other treatments have not been effective.

Uses of Elbonix 50 mg Tablets

• Treatment of Chronic Immune Thrombocytopenia (ITP)
• Management of Aplastic Anemia
• Treatment of thrombocytopenia in Hepatitis C patients
• Helps reduce risk of bleeding and bruising

Benefits of Elbonix 50 mg

• Boosts platelet production naturally
• Reduces dependence on platelet transfusions
• Helps prevent excessive bleeding
• Improves patient quality of life
• Easy-to-use once-daily oral tablet

How Elbonix Works

Elbonix (eltrombopag) stimulates thrombopoietin (TPO) receptors in the bone marrow, encouraging the body to produce more platelets and maintain healthy levels.

Side Effects of Elbonix 50 mg Tablets

Common Side Effects

• Headache
• Nausea
• Fatigue
• Diarrhea
• Muscle pain

Serious Side Effects

• Liver function abnormalities
• Increased risk of blood clots (thrombosis)
• Cataracts with prolonged use
• Severe allergic reactions (rare)

Precautions & Warnings

• Regular liver function and platelet monitoring required
• Avoid taking with milk, calcium, or mineral supplements
• Use cautiously in patients with liver disease
• Not recommended during pregnancy unless prescribed
• Follow medical advice strictly

Dosage & Administration

• Usually taken once daily on an empty stomach
• Take at least 1–2 hours before or after meals
• Avoid antacids or supplements near dosing time
• Follow your doctor’s prescription carefully

Packaging Information

• Pack size: 28 tablets
• Suitable for continuous treatment

Conclusion

Elbonix 50 mg Tablets (28’s) is an effective solution for managing thrombocytopenia in patients with chronic blood disorders. With proper monitoring and usage, it significantly reduces bleeding risks and improves overall health outcomes.